TLR2 and neoplasm: TLRs regulate host defense mechanisms, elicit pro-tumorigenic responses, and could be deemed potential biomarkers to monitor tumor progression, specifically TLR4 in tumor survival and chemoresistance, and TLR2 in metastatic progression (29-32).